GC Biopharma

GC Biopharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GC Biopharma (006280.KS) as of Oct 12, 2026 is 69.15 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 46.52 B KRW — a change of 48.64% (higher).

EBITDA

69.15 BKRW

YoY

48.64%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GC Biopharma is 2025 69.15 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GC Biopharma was 2024 46.52 B KRW. It decreases by 48.64% higher compared to the previous year.

The GC Biopharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
54.55 B KRW
Jan 1, 2019
46.22 B KRW
Jan 1, 2020
56.91 B KRW
Jan 1, 2021
81.87 B KRW
Jan 1, 2022
111.11 B KRW
Jan 1, 2023
46.53 B KRW
Jan 1, 2024
46.52 B KRW
Jan 1, 2025
69.15 B KRW
The GC Biopharma EBITDA history
YEAREBITDAYoY
69.15 BKRW+48.64%
46.52 BKRW-0.03%
46.53 BKRW-58.12%
111.11 BKRW+35.72%
81.87 BKRW+43.85%
56.91 BKRW+23.13%
46.22 BKRW-15.27%
54.55 BKRW-42.28%
94.50 BKRW+13.82%
83.03 BKRW-13.47%
95.95 BKRW-4.61%
100.59 BKRW—
Access this data via the Eulerpool API
Get Free API Key

GC Biopharma Stock analysis

What does GC Biopharma do? GC Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GC Biopharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GC Biopharma is 69.15 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of GC Biopharma changed from 46.52 B KRW to 69.15 B KRW, representing a 48.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) GC Biopharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s GC Biopharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — GC Biopharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GC Biopharma